Bristol Myers Squibb expands Nvidia partnership to supercharge its AI drug factory

Bristol Myers Squibb expands its Nvidia AI factory partnership, reporting 55% cost savings on drug discovery workloads. Here’s what it means for investors.

The post Bristol Myers Squibb expands Nvidia partnership to supercharge its AI drug factory appeared first on Crypto Briefing.